The SIAMS-ED trial: A national, independent, multicentre study on cardiometabolic and hormonal impairment of men with erectile dysfunction treated with vardenafil

International Journal of Endocrinology

Volumn 2014, Issue , 2014, Pages

  Andò, Sebastiano ^f   Angelletti, Gabriella ^f   Matteo, Baldi ^f   Balercia, Giancarlo ^f   Giuseppe, Bellastella ^f   Bonsanto, Mario ^f   Calogero, Aldo Eugenio ^f   Canale, Domenico ^f   Caprio, Massimiliano ^f   Caretta, Nicola ^f   Erennio, Ciotoli ^f   Colpi, Giovanni Maria ^f   Fabbri, Andrea ^f   Fornengo, Riccardo ^f   Francavilla, Sandro ^f   Francomano, Davide ^f   Gavioli, Silvia ^f   Angelo, Giagulli Vito ^f   Giannetta, Elisa ^f   Goglia, Umberto ^f   Nicola, Ilacqua ^f   La Vignera, Sandro ^f   Lemma, Andrea ^f   Mancini, Mario ^f   Manieri, Chiara ^f   Mansani, Riccardo ^f   Tommaso, Ministrini ^f   Minuto, Francesco ^f   Alessandro, Oppo ^f   Paggi, Francesca ^f   Rosario, Pivonello ^f   Fiore, Pelliccione ^f   Anna, Perri ^f   Perrini, Sebastio ^f   Riccardo, Pofi ^f   Pozza, Carlotta ^f   Sbardella, Emilia ^f   Stefano, Serra ^f   Sinisi, Antonio ^f   more..

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b BELLARIA HOSPITAL   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e UNIVERSITY OF FLORENCE   (Italy)

^f Italian Society of Andrology and Sexual Medicine (SIAMS)   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VARDENAFIL;

ADULT; AGE DISTRIBUTION; ANDROGEN BLOOD LEVEL; ARTICLE; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; ENDOCRINE DISEASE; ERECTILE DYSFUNCTION; FOLLOW UP; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTICENTER STUDY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PULSE PRESSURE; TESTOSTERONE BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 84901770604     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2014/858715     Document Type: Article

References (68)

1. Lewis R. W., Fugl-Meyer K. S., Corona G., Hayes R. D., Laumann E. O., Moreira E. D., Rellini A. H., Segraves T., Definitions/epidemiology/risk factors for sexual dysfunction. Journal of Sexual Medicine 2010 7 4 1598 1607 2-s2.0-77955257328 10.1111/j.1743-6109.2010.01778.x
2. Esposito K., Giugliano F., Martedì E., Feola G., Marfella R., D'Armiento M., Giugliano D., High proportions of erectile dysfunction in men with the metabolic syndrome. Diabetes Care 2005 28 5 1201 1203 2-s2.0-18144378359 10.2337/diacare.28.5.1201 (Pubitemid 40616635)
3. De Berardis G., Franciosi M., Belfiglio M., Di Nardo B., Greenfield S., Kaplan S. H., Pellegrini F., Sacco M., Tognoni G., Valentini M., Nicolucci A., Erectile dysfunction and quality of life in type 2 diabetic patients: a serious problem too often overlooked. Diabetes Care 2002 25 2 284 291 2-s2.0-17144437209 10.2337/diacare.25.2.284 (Pubitemid 41079623)
4. Burchardt M., Burchardt T., Baer L., Kiss A. J., Pawar R. V., Shabsigh A., De La Taille A., Hayek O. R., Shabsigh R., Hypertension is associated with severe erectile dysfunction. Journal of Urology 2000 164 4 1188 1191 2-s2.0-0033822704
5. Suetomi T., Kawai K., Hinotsu S., Joraku A., Oikawa T., Sekido N., Miyanaga N., Shimazui T., Akaza H., Negative impact of metabolic syndrome on the responsiveness to sildenafil in Japanese men. Journal of Sexual Medicine 2008 5 6 1443 1450 2-s2.0-44949260973 10.1111/j.1743-6109.2007.00747.x (Pubitemid 351803110)
6. Alberti K. G. M. M., Eckel R. H., Grundy S. M., Zimmet P. Z., Cleeman J. I., Donato K. A., Fruchart J.-C., James W. P. T., Loria C. M., Smith S. C., Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 2009 120 16 1640 1645 2-s2.0-70350245011 10.1161/CIRCULATIONAHA.109.192644
7. Corona G., Monami M., Rastrelli G., Melani C., Balzi D., Sforza A., Forti G., Mannucci E., Maggi M., Is metabolic syndrome a useless category in subjects with high cardiovascular risk? Results from a cohort study in men with erectile dysfunction. Journal of Sexual Medicine 2011 8 2 504 511 2-s2.0-79551478570 10.1111/j.1743-6109.2010.02126.x
8. Aizawa Y., Kamimura N., Watanabe H., Aizawa Y., Makiyama Y., Usuda Y., Watanabe T., Kurashina Y., Cardiovascular risk factors are really linked in the metabolic syndrome: this phenomenon suggests clustering rather than coincidence. International Journal of Cardiology 2006 109 2 213 218 2-s2.0-33747073988 10.1016/j.ijcard.2005.06.007 (Pubitemid 44389480)
9. Aversa A., Isidori A. M., Gianfrilli D., Greco E. A., Graziottin A., Zizzo G., Lenzi A., Fabbri A., Are subjects with erectile dysfunction aware of their condition? Results from a retrospective study based on an Italian free-call information service. Journal of Endocrinological Investigation 2004 27 6 548 556 2-s2.0-4544373920 (Pubitemid 39255505)
10. Jones T. H., Saad F., The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process. Atherosclerosis 2009 207 2 318 327 2-s2.0-70549086629 10.1016/j.atherosclerosis.2009.04.016
11. Basaria S., Muller D. C., Carducci M. A., Egan J., Dobs A. S., Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy. Cancer 2006 106 3 581 588 2-s2.0-31544440178 10.1002/cncr.21642 (Pubitemid 43157621)
12. Franklin S. S., Khan S. A., Wong N. D., Larson M. G., Levy D., Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 1999 100 4 354 360 2-s2.0-0033609526 (Pubitemid 29362404)
13. Domanski M., Mitchell G., Pfeffer M., Neaton J. D., Norman J., Svendsen K., Grimm R., Cohen J., Stamler J., Pulse pressure and cardiovascular disease-related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT). Journal of the American Medical Association 2002 287 20 2677 2683 2-s2.0-0037157096 (Pubitemid 34533546)
14. Stehouwer C. D. A., Henry R. M. A., Ferreira I., Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia 2008 51 4 527 539 2-s2.0-41149168064 10.1007/s00125-007-0918-3
15. Mannucci E., Lambertucci L., Monami M., Fedeli A., Chiasserini V., Marchionni N., Masotti G., Ungar A., Pulse pressure and mortality in hypertensive type 2 diabetic patients. A cohort study. Diabetes/Metabolism Research and Reviews 2006 22 3 172 175 2-s2.0-33744466568 10.1002/dmrr.598 (Pubitemid 43805396)
16. Hajjar I., Kotchen T. A., Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. Journal of the American Medical Association 2003 290 2 199 206 2-s2.0-0038690424 10.1001/jama.290.2.199 (Pubitemid 37430058)
17. Assmann G., Cullen P., Evers T., Petzinna D., Schulte H., Importance of arterial pulse pressure as a predictor of coronary heart disease risk in PROCAM. European Heart Journal 2005 26 20 2120 2126 2-s2.0-26044479361 10.1093/eurheartj/ehi467 (Pubitemid 41407994)
18. Corona G., Mannucci E., Lotti F., Fisher A. D., Bandini E., Balercia G., Forti G., Maggi M., Pulse pressure, an index of arterial stiffness, is associated with androgen deficiency and impaired penile blood flow in men with ED. Journal of Sexual Medicine 2009 6 1 285 293 2-s2.0-58149513375 10.1111/j.1743-6109.2008.01059.x
19. Kienitz T., Quinkler M., Testosterone and blood pressure regulation. Kidney and Blood Pressure Research 2008 31 2 71 79 2-s2.0-43049096819 10.1159/000119417 (Pubitemid 351630063)
20. Isidori A. M., Buvat J., Corona G., A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment-a systematic review. European Urology 2014 65 99 112
21. Manzoli L., Palumbo W., Ruotolo P., Panella M., Mezzetti A., Di Stanislao F., Cardiovascular risk of the general population assessed through SCORE and CUORE charts: an extensive survey by the general practitioners from Abruzzo, Italy. International Journal of Cardiology 2010 144 1 47 52 2-s2.0-77957885201 10.1016/j.ijcard.2009.03.129
22. Palmieri L., Rielli R., Demattè L., Donfrancesco C., Ciccarelli P., De Sanctis Caiola P., Dima F., Noce C. L., Brignoli O., Cuffari A., Giampaoli S., CUORE project: implementation of the 10-year risk score. European Journal of Cardiovascular Prevention and Rehabilitation 2011 18 4 642 649 2-s2.0-80054875974 10.1177/1741826710389925
23. Jannini E. A., Isidori A. M., Aversa A., Lenzi A., Althof S. E., Which is first? The controversial issue of precedence in the treatment of male sexual dysfunctions. The Journal of Sexual Medicine 2013 10 2359 2369
24. Penson D. F., Latini D. M., Lubeck D. P., Wallace K. L., Henning J. M., Lue T. F., Do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than the general population of impotent patients? Results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction (ExCEED) database. Diabetes Care 2003 26 4 1093 1099 2-s2.0-0042167567 10.2337/diacare.26.4.1093 (Pubitemid 36929254)
25. Jannini E. A., Isidori A. M., Gravina G. L., Aversa A., Balercia G., Bocchio M., Boscaro M., Carani C., Corona G., Fabbri A., Foresta C., Forti G., Francavilla S., Granata A. R. M., Maggi M., Mansani R., Palego P., Spera G., Vetri M., Lenzi A., Carosa E., Di Tommaso S., Bruzziches R., Francomano D., Gianfrilli D., Pozza C., Giannetta E., Selice R., Caretta N., Paggi F., Buldreghini E., Magini A., Krausz C., Caprio M., De Martino M. U., Falcone S., Ruggiero A., Guidi A., De Mola G., Pugni V., The ENDOTRIAL Study: a spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction. Journal of Sexual Medicine 2009 6 9 2547 2560 2-s2.0-69949089081 10.1111/j.1743-6109.2009.01375.x
26. Rosen R. C., Cappelleri J. C., Gendrano N. III, The International Index of Erectile Function (IIEF): a state-of-the-science review. International Journal of Impotence Research 2002 14 4 226 244 2-s2.0-0036668536 10.1038/sj.ijir.3900857 (Pubitemid 34947726)
27. Palmieri L., Panico S., Vanuzzo D., Ferrario M., Pilotto L., Sega R., Cesana G., Giampaoli S., Evaluation of the global cardiovascular absolute risk: The Progetto CUORE individual score. Annali dell'Istituto Superiore di Sanita 2004 40 4 393 399 2-s2.0-21344458148 (Pubitemid 40904325)
28. Gianfrilli D., Lauretta R., Di D. C., Propionyl-L-carnitine, L-arginine and niacin in sexual medicine: a nutraceutical approach to erectile dysfunction. Andrologia 2012 44 supplement 1 600 604
29. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002 106 3143 3421
30. Isidori A. M., Giannetta E., Lenzi A., Male hypogonadism. Pituitary 2008 11 2 171 180 2-s2.0-43049173754 10.1007/s11102-008-0111-9
31. Aversa A., Bruzziches R., Spera G., Diagnosing erectile dysfunction: the penile dynamic colour duplex ultrasound revisited. International Journal of Andrology 2005 28 supplement 2 61 63 2-s2.0-28344450834 (Pubitemid 41719776)
32. Mancia G., Bombelli M., Corrao G., Facchetti R., Madotto F., Giannattasio C., Trevano F. Q., Grassi G., Zanchetti A., Sega R., Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis. Hypertension 2007 49 1 40 47 2-s2.0-33847630752 10.1161/01.HYP.0000251933.22091.24 (Pubitemid 46360339)
33. Thompson I. M., Tangen C. M., Goodman P. J., Probstfield J. L., Moinpour C. M., Coltman C. A., Erectile dysfunction and subsequent cardiovascular disease. Journal of the American Medical Association 2005 294 23 2996 3002 2-s2.0-29144533834 10.1001/jama.294.23.2996 (Pubitemid 41817661)
34. Corona G., Monami M., Boddi V., Cameron-Smith M., Lotti F., de Vita G., Melani C., Balzi D., Sforza A., Forti G., Mannucci E., Maggi M., Male sexuality and cardiovascular risk. A cohort study in patients with erectile dysfunction. Journal of Sexual Medicine 2010 7 5 1918 1927 2-s2.0-77953580306 10.1111/j.1743-6109.2010.01744.x
35. Nehra A., Jackson G., Miner M., The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clinic Proceedings 2012 87 766 778
36. Rosen R. O., Fisher W. A., Eardley I., Niederberger C., Nadel A., Sand M., The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Current Medical Research and Opinion 2004 20 5 607 617 2-s2.0-2542438558 10.1185/030079904125003467 (Pubitemid 38685004)
37. Kirby M. G., Schnetzler G., Zou K. H., Symonds T., Prevalence and detection rate of underlying disease in men with erectile dysfunction receiving phosphodiesterase type 5 inhibitors in the United Kingdom: a retrospective database study. International Journal of Clinical Practice 2011 65 7 797 806 2-s2.0-79959325737 10.1111/j.1742-1241.2011.02693.x
38. Frantzen J., Speel T. G. W., Kiemeney L. A., Meuleman E. J. H., Cardiovascular risk among men seeking help for erectile dysfunction. Annals of Epidemiology 2006 16 2 85 90 2-s2.0-32044452724 10.1016/j.annepidem.2005.06.047 (Pubitemid 43197599)
39. Rosano G. M. C., Leonardo F., Pagnotta P., Pelliccia F., Panina G., Cerquetani E., Della Monica P. L., Bonfigli B., Volpe M., Chierchia S. L., Acute anti-ischemic effect of testosterone in men with coronary artery disease. Circulation 1999 99 13 1666 1670 2-s2.0-0033528723 (Pubitemid 29162477)
40. Dockery F., Bulpitt C. J., Agarwal S., Vernon C., Rajkumar C., Effect of androgen suppression compared with androgen receptor blockade on arterial stiffness in men with prostate cancer. Journal of Andrology 2009 30 4 410 415 2-s2.0-68549130708 10.2164/jandrol.108.006924
41. Hougaku H., Fleg J. L., Najjar S. S., Lakatta E. G., Harman S. M., Blackman M. R., Metter E. J., Relationship between androgenic hormones and arterial stiffness, based on longitudinal hormone measurements. American Journal of Physiology 2006 290 2 E234 E242 2-s2.0-33644867881 10.1152/ajpendo.00059. 2005
42. Corona G., Monami M., Boddi V., Rastrelli G., Melani C., Balzi D., Sforza A., Forti G., Mannucci E., Maggi M., Pulse pressure independently predicts major cardiovascular events in younger but not in older subjects with erectile dysfunction. Journal of Sexual Medicine 2011 8 1 247 254 2-s2.0-78650766553 10.1111/j.1743-6109.2010.01966.x
43. Aversa A., Francomano D., Bruzziches R., Pili M., Natali M., Spera G., Lenzi A., The application of digital pulse amplitude tonometry to the diagnostic investigation of endothelial dysfunction in men with erectile dysfunction. Andrologia 2011 43 1 9 15 2-s2.0-78651258375 10.1111/j.1439-0272.2009.00998.x
44. Giannetta E., Gianfrilli D., Barbagallo F., Isidori A. M., Lenzi A., Subclinical male hypogonadism. Best Practice & Research Clinical Endocrinology & Metabolism 2012 26 539 550
45. Labropoulos B., Velonakis E., Oekonomakos P., Serum sex hormones in patients with coronary disease and their relationship to known factors causing atherosclerosis. Cardiology 1982 69 2 98 103 2-s2.0-0019945072 (Pubitemid 12080435)
46. Corona G., Mannucci E., Ricca V., Lotti F., Boddi V., Bandini E., Balercia G., Forti G., Maggi M., The age-related decline of testosterone is associated with different specific symptoms and signs in patients with sexual dysfunction. International Journal of Andrology 2009 32 6 720 728 2-s2.0-69949087994 10.1111/j.1365-2605.2009.00952.x
47. Saad F., Aversa A., Isidori A. M., Zafalon L., Zitzmann M., Gooren L., Onset of effects of testosterone treatment and time span until maximum effects are achieved. European Journal of Endocrinology 2011 165 5 675 685 2-s2.0-80054827093 10.1530/EJE-11-0221
48. Hughes G. S., Mathur R. S., Margolius H. S., Sex steroid hormones are altered in essential hypertension. Journal of Hypertension 1989 7 3 181 187 2-s2.0-0024524467 (Pubitemid 19093890)
49. Svartberg J., von Mühlen D., Schirmer H., Barrett-Connor E., Sundfjord J., Jorde R., Association of endogenous testosterone with blood pressure and left ventricular mass in men. The Tromsø study. European Journal of Endocrinology 2004 150 1 65 71 2-s2.0-0742289422 10.1530/eje.0. 1500065 (Pubitemid 38159742)
50. Isidori A. M., Lenzi A., Risk factors for androgen decline in older males: lifestyle, chronic diseases and drugs. Journal of Endocrinological Investigation 2005 28 3 14 22 2-s2.0-23244441018
51. Reaven G. M., The metabolic syndrome: requiescat in pace. Clinical Chemistry 2005 51 6 931 938 2-s2.0-19644394512 10.1373/clinchem.2005.048611 (Pubitemid 40740871)
52. Grundy S. M., Point: The metabolic syndrome still lives. Clinical Chemistry 2005 51 8 1352 1354 2-s2.0-23044447258 10.1373/clinchem.2005.050989 (Pubitemid 41060865)
53. Reaven G., Counterpoint: Just being alive is not good enough. Clinical Chemistry 2005 51 8 1354 1357 2-s2.0-23044509644 10.1373/clinchem.2005.053587 (Pubitemid 41060866)
54. Mannucci E., Monami M., Rotella C. M., How many components for the metabolic syndrome? Results of exploratory factor analysis in the FIBAR study. Nutrition, Metabolism and Cardiovascular Diseases 2007 17 10 719 726 2-s2.0-36048945994 10.1016/j.numecd.2006.09.003 (Pubitemid 350088439)
55. Wormser D., Kaptoge S., Di Angelantonio E., Wood A. M., Pennells L., Thompson A., Sarwar N., Kizer J. R., Lawlor D. A., Nordestgaard B. G., Ridker P., Salomaa V., Stevens J., Woodward M., Sattar N., Collins R., Thompson S. G., Whitlock G., Danesh J., Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. The Lancet 2011 377 9771 1085 1095 2-s2.0-79953163759 10.1016/S0140-6736(11)60105-0
56. Pasquali D., Arcopinto M., Renzullo A., Cardiovascular abnormalities in Klinefelter Syndrome. International Journal of Cardiology 2013 168 2 754 759
57. Corona G., Rastrelli G., Monami M., Guay A., Buvat J., Sforza A., Forti G., Mannucci E., Maggi M., Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. European Journal of Endocrinology 2011 165 5 687 701 2-s2.0-80054797449 10.1530/EJE-11-0447
58. Nehra A., Erectile dysfunction and cardiovascular disease: efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditions. Mayo Clinic Proceedings 2009 84 2 139 148 2-s2.0-61449117843 10.4065/84.2.139
59. Goldstein I., Young J. M., Fischer J., Bangerter K., Segerson T., Taylor T., Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study. Diabetes Care 2003 26 3 777 783 2-s2.0-0042405173 10.2337/diacare.26.3.777 (Pubitemid 36929343)
60. Van Ahlen H., Wahle K., Kupper W., Yassin A., Reblin T., Neureither M., Safety and efficacy of vardenafil, a selective phosphodiesterase 5 inhibitor, in patients with erectile dysfunction and arterial hypertension treated with multiple antihypertensives. Journal of Sexual Medicine 2005 2 6 856 864 2-s2.0-28444487883 10.1111/j.1743-6109.2005.00150.x (Pubitemid 41727399)
61. Miner M., Gilderman L., Bailen J., Cook D., Dawson K., Stanislaus M., Beresford E., Barnes A., Vardenafil in men with stable statin therapy and dyslipidemia. Journal of Sexual Medicine 2008 5 6 1455 1467 2-s2.0-44949122597 10.1111/j.1743-6109.2008.00820.x (Pubitemid 351803112)
62. Eardley I., Lee J. C., Shabsigh R., Dean J., Maggi M., Neuser D., Norenberg C., Vardenafil improves erectile function in men with erectile dysfunction and associated underlying conditions, irrespective of the use of concomitant medications. Journal of Sexual Medicine 2010 7 1 244 255 2-s2.0-74049102684 10.1111/j.1743-6109.2009.01547.x
63. Schneider T., Gleißner J., Merfort F., Hermanns M., Beneke M., Ulbrich E., Efficacy and safety of vardenafil for the treatment of erectile dysfunction in men with metabolic syndrome: results of a randomized, placebo-controlled trial. Journal of Sexual Medicine 2011 8 10 2904 2911 2-s2.0-80053565616 10.1111/j.1743-6109.2011.02383.x
64. van Ahlen H., Zumbé J., Stauch K., Hanisch J. U., The Real-Life Safety and Efficacy of Vardenafil (REALISE) Study: results in men from Europe and overseas with erectile dysfunction and cardiovascular or metabolic conditions. Journal of Sexual Medicine 2010 7 9 3161 3169 2-s2.0-77956272479 10.1111/j.1743-6109.2010.01921.x
65. Fonseca V., Seftel A., Denne J., Fredlund P., Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials. Diabetologia 2004 47 11 1914 1923 2-s2.0-12144285424 10.1007/s00125-004-1549-6 (Pubitemid 40110198)
66. Miner M. M., Barnes A., Janning S., Efficacy of phosphodiesterase type 5 inhibitor treatment in men with erectile dysfunction and dyslipidemia: a post hoc analysis of the vardenafil statin study. Journal of Sexual Medicine 2010 7 5 1937 1947 2-s2.0-77953573222 10.1111/j.1743-6109.2010.01766.x
67. Lopez-Gonzalez E., Herdeiro M. T., Figueiras A., Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Safety 2009 32 1 19 31 2-s2.0-58149394706 10.2165/00002018-200932010-00002
68. Giannetta E., Isidori A. M., Galea N., Carbone I., Mandosi E., Vizza C. D., Naro F., Morano S., Fedele F., Lenzi A., Chronic inhibition of cyclic GMP phosphodiesterase 5A improves diabetic cardiomyopathy: a randomized, controlled clinical trial using magnetic resonance imaging with myocardial tagging. Circulation 2012 125 2323 2333